Yuhan Corporation
000100
Clasificación en acciones
#3832
Yuhan Corporation, a prominent South Korean pharmaceutical firm established in... Yuhan Corporation, a prominent South Korean pharmaceutical firm established in 1926 and headquartered in Seoul, specializes in the research, development, and manufacture of active pharmaceutical ingredients (APIs) and intermediates for both domestic and international markets. Its extensive product portfolio encompasses a wide array of prescription pharmaceuticals (ETC), addressing therapeutic areas such as cardiovascular, alimentary, genito-urinary, metabolic, respiratory, allergy, and neurological systems, alongside anti-infectives, anti-cancer treatments, and hormonal therapies. Notable offerings include Revanex, an acid pump antagonist designed for treating peptic ulcers and gastritis-related mucosal injury. Beyond prescription drugs, Yuhan Corporation provides a diverse range of over-the-counter (OTC) medications, including vitamins, mineral supplements, hepatopathy treatments, tonics, and drugs for respiratory, alimentary, dermatological, and pain relief applications. The company also extends its reach into consumer health and household goods, producing items like bleaches, detergents, pesticides, and oral care products. Further diversifying its operations, Yuhan is involved in the dental sector, supplying implants, equipment, consumables, and dental care solutions, and manufactures veterinary medical supplies for livestock, aquatic species, and companion animals. Additionally, it offers contract manufacturing services to other businesses.
Precio por acción
$63.22
Capitalización bursátil
$4.27B
Cambio (1 día)
-3.12%
Cambio (1 año)
-23.57%
País
KR
Comercio Yuhan Corporation (000100)
Categoría
Healthcare
Ingresos de Yuhan Corporation (000100)
Ingresos en Jun 2026 TTM: $1.72B
Según los últimos informes financieros de Yuhan Corporation, los ingresos actuales de la empresa (TTM) son $1.72B. En 2024, la empresa obtuvo unos ingresos de $1.41B una disminución en comparación con los ingresos del año 2023, que fueron de $1.44B. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Yuhan Corporation desde 2007 hasta 2026
Ingresos al final de cada año
| Año | Ingresos | Cambiar |
|---|---|---|
| 2026 (TTM) | $1.72B | 13.61% |
| 2025 | $1.51B | 7.62% |
| 2024 | $1.41B | -2.06% |
| 2023 | $1.44B | 2.04% |
| 2022 | $1.41B | -0.87% |
| 2021 | $1.42B | -4.85% |
| 2020 | $1.49B | 16.39% |
| 2019 | $1.28B | -6.01% |
| 2018 | $1.36B | -0.59% |
| 2017 | $1.37B | 25.25% |
| 2016 | $1.10B | 14.05% |
| 2015 | $960.45M | 3.29% |
| 2014 | $929.82M | 3.74% |
| 2013 | $896.29M | 22.88% |
| 2012 | $729.40M | 24.46% |
| 2011 | $586.04M | -0.96% |
| 2010 | $591.75M | 6.18% |
| 2009 | $557.33M | 17.68% |
| 2008 | $473.59M | -10.14% |
| 2007 | $527.01M | 0.00% |
Ingresos de empresas similares o competidoras
| Empresa | Ingresos | Diferencia de ingresos | País |
|---|---|---|---|
| $23.54B | 1,268.60% |
DE
|
|
| $23.73B | 1,280.21% |
DE
|
|
| $29.24B | 1,600.31% |
JP
|
|
| $5.85B | 240.11% |
CH
|
|
| $6.34B | 268.81% |
IN
|
